Market Overview:
The global neurostimulator device market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as the increasing prevalence of neurological disorders, technological advancements in neurostimulator devices, and rising demand for minimally invasive surgeries. Based on type, the global neurostimulator device market is segmented into stationary neurostimulators and portable neurostimulators. The stationary neurostimulators segment is further divided into implantable and non-implantable devices. The implantable devices segment is expected to grow at a higher CAGR during the forecast period owing to their ability to provide long-term relief from pain symptoms caused by various neurological disorders. Based on application, the global Neuro stimulator Device Market is classified into hospitals, scientific research institutes, and other applications such as home care settings and pain clinics.
Product Definition:
A neurostimulator is a device that sends electrical signals to specific areas of the brain. This can help to improve the symptoms of conditions such as epilepsy, Parkinson's disease, and chronic pain.
Stationary Neurostimulator:
Stationary neurostimulator is a device that delivers electrical stimulation to the vagus nerve, which in turn produces an effect on the brain. The primary function of stationary neurostimulators is to control seizures. It works by sending mild pulses of electricity through the vagus nerve (the longest and most prominent cranial nerves) towards the brain, thereby producing a calming effect on patients suffering from epilepsy or other seizure disorders.
Portable Neurostimulator:
A portable neurostimulator is a medical device used to deliver electrical stimulation to the vagus nerve, which in turn provides relief from symptoms of depression. It is also used for providing treatment for post-acute stroke and traumatic brain injury patients. The product consists of an implantable pulse generator (IPG) and leads that are connected by wireless technology to an external monitor that displays information pertaining to battery life, therapy type, therapy settings, and patient data.
Application Insights:
The hospital segment dominated the global market in 2017. Stationary neurostimulators are used for treating disorders that require precise electrical stimulation, such as Parkinson¢â‚¬â„¢s disease and epilepsy. Portable neurostimulators are mainly used for rehabilitation after brain injury or stroke, which is expected to drive the portable neurostimulator segment over the forecast period. Increasing number of patients suffering from neurological conditions is anticipated to further boost product demand in this application segment over the forecast period.
Increasing adoption of advanced technologies such as deep brain stimulation and spinal cord stimulators among other applications is expected to drive growth in scientific research sector over the forecast period owing to increasing R&D activities pertaining these devices across various institutions globally.
Regional Analysis:
North America dominated the global market in 2017 owing to favorable reimbursement policies, increasing prevalence of chronic diseases such as Parkinson’s and epilepsy, and high adoption of technologically advanced products. The U.S. is one of the most lucrative markets for medical devices due to factors such as a large geriatric population base suffering from neurodegenerative disorders and rising incidences of various neurological conditions including brain tumor, stroke, Parkinson's disease (PD), Huntington's disease (HD), Alzheimer's disease (AD) & multiple sclerosis (MS). According to statistics published by National Institute on Neurological Disorders & Stroke/Brain Tumor Foundation in 2018; over 60,000 people are diagnosed with a primary brain tumor every year in the U.S.
Growth Factors:
- Increasing prevalence of neurological disorders: The global prevalence of neurological disorders is increasing rapidly. This is mainly due to the aging population and the increase in lifestyle-related diseases. The Neurostimulator Device market is expected to grow significantly as a result of this trend.
- Advances in technology: Neurostimulator Device technology is constantly evolving, with new devices being developed that are more effective and easier to use. This will help drive growth in the market over the next few years.
- Growing awareness about neurostimulation therapy: There is growing awareness among patients and healthcare professionals about the benefits of neurostimulation therapy for treating various neurological conditions. This will help boost demand for Neurostimulator Devices in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neurostimulator Device Market Research Report
By Type
Stationary Neurostimulator, Portable Neurostimulator
By Application
Hospital, Scientific Research, Other
By Companies
Cyberonics, Abiomed, MED-EL, Philips Healthcare, Cardiac Science, Zoll Medical, Schiller, Nihon Kohden, GE Healthcare, Cochlear, Boston Scientific, Biotronik, Sorin Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Neurostimulator Device Market Report Segments:
The global Neurostimulator Device market is segmented on the basis of:
Types
Stationary Neurostimulator, Portable Neurostimulator
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Scientific Research, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cyberonics
- Abiomed
- MED-EL
- Philips Healthcare
- Cardiac Science
- Zoll Medical
- Schiller
- Nihon Kohden
- GE Healthcare
- Cochlear
- Boston Scientific
- Biotronik
- Sorin Group
Highlights of The Neurostimulator Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Stationary Neurostimulator
- Portable Neurostimulator
- By Application:
- Hospital
- Scientific Research
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neurostimulator Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A neurostimulator device is a medical device that uses electrical stimulation to treat conditions such as epilepsy, Parkinson's disease, and chronic pain.
Some of the key players operating in the neurostimulator device market are Cyberonics, Abiomed, MED-EL, Philips Healthcare, Cardiac Science, Zoll Medical, Schiller, Nihon Kohden, GE Healthcare, Cochlear, Boston Scientific, Biotronik, Sorin Group.
The neurostimulator device market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurostimulator Device Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neurostimulator Device Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neurostimulator Device Market - Supply Chain
4.5. Global Neurostimulator Device Market Forecast
4.5.1. Neurostimulator Device Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neurostimulator Device Market Size (000 Units) and Y-o-Y Growth
4.5.3. Neurostimulator Device Market Absolute $ Opportunity
5. Global Neurostimulator Device Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Neurostimulator Device Market Size and Volume Forecast by Type
5.3.1. Stationary Neurostimulator
5.3.2. Portable Neurostimulator
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Neurostimulator Device Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Neurostimulator Device Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Scientific Research
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Neurostimulator Device Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Neurostimulator Device Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Neurostimulator Device Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Neurostimulator Device Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Neurostimulator Device Demand Share Forecast, 2019-2026
9. North America Neurostimulator Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Neurostimulator Device Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Neurostimulator Device Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Scientific Research
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Neurostimulator Device Market Size and Volume Forecast by Type
9.7.1. Stationary Neurostimulator
9.7.2. Portable Neurostimulator
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Neurostimulator Device Demand Share Forecast, 2019-2026
10. Latin America Neurostimulator Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Neurostimulator Device Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Neurostimulator Device Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Scientific Research
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Neurostimulator Device Market Size and Volume Forecast by Type
10.7.1. Stationary Neurostimulator
10.7.2. Portable Neurostimulator
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Neurostimulator Device Demand Share Forecast, 2019-2026
11. Europe Neurostimulator Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Neurostimulator Device Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Neurostimulator Device Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Scientific Research
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Neurostimulator Device Market Size and Volume Forecast by Type
11.7.1. Stationary Neurostimulator
11.7.2. Portable Neurostimulator
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Neurostimulator Device Demand Share, 2019-2026
12. Asia Pacific Neurostimulator Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Neurostimulator Device Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Neurostimulator Device Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Scientific Research
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Neurostimulator Device Market Size and Volume Forecast by Type
12.7.1. Stationary Neurostimulator
12.7.2. Portable Neurostimulator
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Neurostimulator Device Demand Share, 2019-2026
13. Middle East & Africa Neurostimulator Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Neurostimulator Device Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Neurostimulator Device Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Scientific Research
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Neurostimulator Device Market Size and Volume Forecast by Type
13.7.1. Stationary Neurostimulator
13.7.2. Portable Neurostimulator
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Neurostimulator Device Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Neurostimulator Device Market: Market Share Analysis
14.2. Neurostimulator Device Distributors and Customers
14.3. Neurostimulator Device Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cyberonics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abiomed
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. MED-EL
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Philips Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cardiac Science
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Zoll Medical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Schiller
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Nihon Kohden
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. GE Healthcare
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cochlear
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Boston Scientific
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Biotronik
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Sorin Group
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
